CKD Corporation
CKD Corporation Fundamental Analysis
CKD Corporation (6407.T) shows moderate financial fundamentals with a PE ratio of 22.79, profit margin of 8.44%, and ROE of 9.19%. The company generates $152.6B in annual revenue with strong year-over-year growth of 15.78%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 59.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 6407.T's fundamental strength across five key dimensions:
Efficiency Score
Weak6407.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate6407.T shows balanced valuation metrics.
Growth Score
Excellent6407.T delivers strong and consistent growth momentum.
Financial Health Score
Excellent6407.T maintains a strong and stable balance sheet.
Profitability Score
Weak6407.T struggles to sustain strong margins.
Key Financial Metrics
Is 6407.T Expensive or Cheap?
P/E Ratio
6407.T trades at 22.79 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 6407.T's PEG of 8.82 indicates potential overvaluation.
Price to Book
The market values CKD Corporation at 2.01 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 15.25 times EBITDA. This signals the market has high growth expectations.
How Well Does 6407.T Make Money?
Net Profit Margin
For every $100 in sales, CKD Corporation keeps $8.44 as profit after all expenses.
Operating Margin
Core operations generate 11.63 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.19 in profit for every $100 of shareholder equity.
ROA
CKD Corporation generates $5.91 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CKD Corporation generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
CKD Corporation generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
6407.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
22.79
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
8.82
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.01
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.92
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.23
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.75
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How 6407.T Stacks Against Its Sector Peers
| Metric | 6407.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 22.79 | 25.83 | Better (Cheaper) |
| ROE | 9.19% | 1278.00% | Weak |
| Net Margin | 8.44% | -43774.00% (disorted) | Weak |
| Debt/Equity | 0.23 | 0.80 | Strong (Low Leverage) |
| Current Ratio | 3.75 | 10.63 | Strong Liquidity |
| ROA | 5.91% | -1539613.00% (disorted) | Weak |
6407.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CKD Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
43.37%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
240.05%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
3.13%
Industry Style: Cyclical, Value, Infrastructure
Growing